Johnson & Johnson (JNJ) Stock: Buy, Sell, or Hold?
JNJ - Johnson & Johnson
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Oct 2, 2026 at $256.03 · last confirmed Oct 21, 2026
Get Alerted When JNJ Hits Your Target Price
Join 10,000+ traders who never miss a move
Interactive Price Chart (1 Month)
Loading historical data...
💡 BUY OPPORTUNITY: JNJ shows positive signals but monitor for confirmation. Market pricing in 5.8% growth. Moderate conviction.
SPY Bullish (stocks from this scanner have beaten SPY by a median 0.37% over the next 20 trading days; JNJ has been on it 4 days). Backtested on 8 months of scanner history vs the S&P 500, as of 2026-10-22.
See all of today's Best Signals in the free scanner →Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 19.4x Exit PE.
In-depth Analysis How we analyze
Technical Outlook: Technically, JNJ is in a strong uptrend. The price is approaching resistance at $269.67. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.8% recently.
Market Sentiment: JNJ scores 61/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
All Signals
- BULLISH: Strong technical setup (61/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.8%)
- NEUTRAL: Near Wall St target ($279.41)
- BULLISH: Expecting earnings turnaround to 5.8% growth with 5.9% revenue growth
- BULLISH: Bottoming setup score 61/100 — corrected, stabilizing, and turning up
Trading Range Analysis
Support & Resistance Levels
Fundamental Context
Data refreshes hourly during market hours. Next update: 1:46 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Is JNJ showing a specific setup today?
Featured in Portfolios
JNJ is a key holding in these high-performance investment strategies.
Top Rated Drug Manufacturers - General Stocks
Top-rated stocks in Drug Manufacturers - General by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ABBV
AbbVie Inc |
STRONG BUY
30 analysts |
$283 | 44 HOLD |
|
GILD
Gilead Sciences Inc |
STRONG BUY
28 analysts |
$160 | 43 HOLD |
|
LLY
Eli Lilly and Company |
STRONG BUY
31 analysts |
$1328 | 27 SELL |
|
BIIB
Biogen Inc |
BUY
36 analysts |
$244 | 39 SELL |
|
MRK
Merck & Company Inc |
STRONG BUY
27 analysts |
$158 | 43 HOLD |
Advanced JNJ Option Strategies
Professional options setups generated by AI based on today's JNJ price and gamma walls.
